183 related articles for article (PubMed ID: 11703362)
1. Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls.
Fischer U; Struss AK; Hemmer D; Pallasch CP; Steudel WI; Meese E
Clin Exp Immunol; 2001 Nov; 126(2):206-13. PubMed ID: 11703362
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.
Pallasch CP; Struss AK; Munnia A; König J; Steudel WI; Fischer U; Meese E
Int J Cancer; 2005 Nov; 117(3):456-9. PubMed ID: 15906353
[TBL] [Abstract][Full Text] [Related]
3. High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma.
He SJ; Gu YY; Yu L; Luo B; Fan R; Lin WZ; Lan XW; Lin YD; Zhang QM; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2014; 7(5):2350-60. PubMed ID: 24966945
[TBL] [Abstract][Full Text] [Related]
4. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.
Behrends U; Schneider I; Rössler S; Frauenknecht H; Golbeck A; Lechner B; Eigenstetter G; Zobywalski C; Müller-Weihrich S; Graubner U; Schmid I; Sackerer D; Späth M; Goetz C; Prantl F; Asmuss HP; Bise K; Mautner J
Int J Cancer; 2003 Aug; 106(2):244-51. PubMed ID: 12800201
[TBL] [Abstract][Full Text] [Related]
5. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.
Ueda R; Yoshida K; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2007 Apr; 120(8):1704-11. PubMed ID: 17230535
[TBL] [Abstract][Full Text] [Related]
6. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
7. Serological identification of URGCP as a potential biomarker for glioma.
Chen LC; Zhang HY; Qin ZY; Wang Y; Mao Y; Yao Y; Zhou LF
CNS Neurosci Ther; 2014 Apr; 20(4):301-7. PubMed ID: 24308561
[TBL] [Abstract][Full Text] [Related]
8. cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients.
Heckel D; Brass N; Fischer U; Blin N; Steudel I; Türeci O; Fackler O; Zang KD; Meese E
Hum Mol Genet; 1997 Nov; 6(12):2031-41. PubMed ID: 9356211
[TBL] [Abstract][Full Text] [Related]
9. Novel immunogenic antigen homologous to hyaluronidase in meningioma.
Heckel D; Comtesse N; Brass N; Blin N; Zang KD; Meese E
Hum Mol Genet; 1998 Nov; 7(12):1859-72. PubMed ID: 9811929
[TBL] [Abstract][Full Text] [Related]
10. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
Solheid C; Lauro G; Palladini G
J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
[TBL] [Abstract][Full Text] [Related]
11. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
[TBL] [Abstract][Full Text] [Related]
12. Human neoplasms elicit multiple specific immune responses in the autologous host.
Sahin U; Türeci O; Schmitt H; Cochlovius B; Johannes T; Schmits R; Stenner F; Luo G; Schobert I; Pfreundschuh M
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11810-3. PubMed ID: 8524854
[TBL] [Abstract][Full Text] [Related]
13. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.
Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K
Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.
Ligon AH; Pershouse MA; Jasser SA; Yung WK; Steck PA
Oncogene; 1997 Mar; 14(9):1075-81. PubMed ID: 9070656
[TBL] [Abstract][Full Text] [Related]
15. Serological analysis of tumor antigens in malignant glioma patients.
Yoshida S; Tanaka R; Ono K
Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M
Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388
[TBL] [Abstract][Full Text] [Related]
17. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
[TBL] [Abstract][Full Text] [Related]
18. Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
Usener D; Gerhardt A; Schadendorf D; Eichmüller S
Br J Dermatol; 2003 Aug; 149(2):282-8. PubMed ID: 12932233
[TBL] [Abstract][Full Text] [Related]
19. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
20. MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.
Comtesse N; Niedermayer I; Glass B; Heckel D; Maldener E; Nastainczyk W; Feiden W; Meese E
Oncogene; 2002 Jan; 21(2):239-47. PubMed ID: 11803467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
